Contact Us
Anticoccidial Drugs Global Market Report 2025
Global Anticoccidial Drugs Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Anticoccidial Drugs Global Market Report 2025

By Drug Class (Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes), By Drug Action (Coccidiostatic, Coccidiocidal), By Application (Poultry, Swine, Fish, Cattle, Companion Animals), By Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Anticoccidial Drugs Market Overview

• Anticoccidial Drugs market size has reached to $1.27 billion in 2024

• Expected to grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%

• Growth Driver: Impact Of Growing Demand For Meat Proteins In The Anticoccidial Drug Market

• Market Trend: Innovative Synthetic Drugs In Anticoccidial Drug Development

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Anticoccidial Drugs Market?

Anticoccidial drugs are a class of medications used to prevent and treat coccidiosis, a parasitic disease of the intestinal tract caused by protozoa of the genus Eimeria. These drugs work by inhibiting various stages of the coccidia life cycle, controlling the infection, and preventing the severe intestinal damage and related symptoms associated with the disease. Anticoccidial drugs are commonly used in veterinary medicine, particularly poultry, to enhance health and productivity by managing this widespread and economically significant condition.

The main drug classes of anticoccidial drugs are ionophores, antibiotics, sulphonamides, chemical derivatives, and others. Ionophores are a type of anticoccidial drug that disrupts the growth and reproduction of coccidia parasites by affecting ion transport across cell membranes. Various drug actions include coccidiostatic and coccidiocidal for a variety of applications, such as poultry, swine, fish, cattle, and companion animals, through different distribution channels, including veterinary hospitals, retail pharmacies, and others.

Anticoccidial Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Anticoccidial Drugs Market Size 2025 And Growth Rate?

The anticoccidial drugs market size has grown strongly in recent years. It will grow from $1.27 billion in 2024 to $1.35 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased incidence of coccidiosis globally, increased adoption of pet animals, high prevalence of coccidiosis, economic impact, and increased safety concerns about food and health of animals.

What Is The Anticoccidial Drugs Market Growth Forecast?

The anticoccidial drugs market size is expected to see strong growth in the next few years. It will grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the growing number of veterinary healthcare, the rising prevalence of coccidiosis in animals, the increasing use of synthetic drugs, the growing demand for feed additives, and increasing livestock production. Major trends in the forecast period include the surge in demand driven by emerging coccidiosis strains, a shift towards natural and alternative treatment methods, increased regulatory scrutiny prompting innovation, rising consumer preferences for antibiotic-free poultry products, advancements in drug delivery technologies, heightened focus on preventive healthcare measures, and expanding applications in aquaculture and companion animal sectors.

The forecast of 6.5% growth over the next five years reflects a modest reduction of 0.7% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. veterinary medicine by inflating prices of coccidiostats like amprolium and toltrazuril manufactured in China and Brazil, resulting in delayed poultry disease management and higher livestock production costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Anticoccidial Drugs Market Segmented?

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

What Is Driving The Anticoccidial Drugs Market? Impact Of Growing Demand For Meat Proteins In The Anticoccidial Drug Market

The growing demand for meat proteins is expected to propel the growth of the anticoccidial drug market going forward. Meat proteins are naturally present in animal flesh, comprising various amino acids essential for various bodily functions. The rising demand for meat proteins is due to population growth, increasing disposable income, urbanization, and changing dietary preferences toward protein-rich foods. Anticoccidial drugs are essential tools in modern livestock farming. They help maintain the health and productivity of animals, ensuring that farmers can meet the growing demand for meat proteins efficiently and sustainably. For instance, in July 2023, according to the report published by the Organization for Economic Co-operation and Development (OECD), a France-based intergovernmental organization, and the Food and Agriculture Organization, an Italy-based specialized agency, in contrast to the projected 2% increase in global average per capita meat demand from the 2020-2022 base period to 2032, the FAO meat price index surged by 10% in 2022 due to lower export supplies. Therefore, the growing demand for meat proteins is driving the growth of the anticoccidial drug industry.

What Is Driving The Anticoccidial Drugs Market? Poultry Farming Surge Drives Anticoccidial Drug Market Growth

The rise in poultry farming is expected to propel the growth of the anticoccidial drug market going forward. Poultry farming refers to raising domesticated birds, such as chickens, turkeys, ducks, and geese, to produce meat, eggs, and feathers. The rise in poultry farming is due to increasing demand for protein, improved farming techniques, and the expansion of global trade. Anticoccidial drugs are often added to poultry feed or water as a preventive measure to protect the birds from coccidiosis during the early and most vulnerable stages of growth. For instance, in June 2023, according to the USDA Economic Research Service, a US-based government administration, the poultry sector's total sales reached $76.9 billion in 2022, a 67% increase from the previous year. Therefore, the rise in poultry farming is driving the growth of the anticoccidial drug industry.

Who Are The Major Players In The Global Anticoccidial Drugs Market?

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

What Are The Key Trends Of The Global Anticoccidial Drugs Market? Innovative Synthetic Drugs In Anticoccidial Drug Development

Major companies operating in the anticoccidial drugs market focus on developing innovative solutions, such as synthetic coccidiostat, to enhance efficacy, minimize resistance development, and address emerging challenges in poultry and livestock management. A synthetic coccidiostat is a chemically engineered compound used to prevent or control coccidiosis by inhibiting the growth and reproduction of coccidia parasites in animals. For instance, in March 2023, Zoetis, a US-based animal health company, launched Avi-Deccox, a reformulated synthetic coccidiostat designed to control coccidiosis in broiler chickens. This product specifically targets the pathogens Eimeria acervulina and Eimeria tenella, which are responsible for significant economic losses in poultry farming. This product features decoquinate as its active ingredient, similar to its predecessor, Deccox. Avi-Deccox addresses the growing issue of resistance linked to the frequent use of ionophores in poultry farming by employing a different mode of action, providing a more effective short-term knock-down effect.

Need data on a specific region in this market?

What Is The Regional Outlook For The Global Anticoccidial Drugs Market?

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Anticoccidial Drugs Market?

The anticoccidial drugs market consist of sales of semduramicin, monensin, lasalocid, salinomycin, decoquinate, amprolium, clopidol, and sulfachloropyrazine. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Anticoccidial Drugs Industry?

The anticoccidial drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anticoccidial drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Anticoccidial Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.35 billion
Revenue Forecast In 2034 $1.75 billion
Growth Rate CAGR of 6.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels Subsegments: 1) By Ionophore: Monensin, Lasalocid, Salinomycin
2) By Antibiotic: Tylosin, Lincomycin, Bacitracin
3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril, Clopidol
5) By Other Drug Classes: Amprolium, Robenidine
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Johnson & Johnson, Merck and Co. Inc, Bayer AG, Novartis AG, Eli Lilly and Company Ltd, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc, Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Anticoccidial Drugs Market Characteristics

3. Anticoccidial Drugs Market Trends And Strategies

4. Anticoccidial Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Anticoccidial Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Anticoccidial Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Anticoccidial Drugs Market Growth Rate Analysis

5.4. Global Anticoccidial Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Anticoccidial Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Anticoccidial Drugs Total Addressable Market (TAM)

6. Anticoccidial Drugs Market Segmentation

6.1. Global Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Ionophore

Antibiotic

Sulphonamides

Chemical Derivative

Other Drug Classes

6.2. Global Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Coccidiostatic

Coccidiocidal

6.3. Global Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Poultry

Swine

Fish

Cattle

Companion Animals

6.4. Global Anticoccidial Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Veterinary Hospitals

Retail Pharmacy

Other Distribution Channels

6.5. Global Anticoccidial Drugs Market, Sub-Segmentation Of Ionophore, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monensin

Lasalocid

Salinomycin

6.6. Global Anticoccidial Drugs Market, Sub-Segmentation Of Antibiotic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tylosin

Lincomycin

Bacitracin

6.7. Global Anticoccidial Drugs Market, Sub-Segmentation Of Sulphonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sulfadimethoxine

Sulfaquinoxaline

6.8. Global Anticoccidial Drugs Market, Sub-Segmentation Of Chemical Derivative, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diclazuril

Clopidol

6.9. Global Anticoccidial Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Amprolium

Robenidine

7. Anticoccidial Drugs Market Regional And Country Analysis

7.1. Global Anticoccidial Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Anticoccidial Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anticoccidial Drugs Market

8.1. Asia-Pacific Anticoccidial Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anticoccidial Drugs Market

9.1. China Anticoccidial Drugs Market Overview

9.2. China Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anticoccidial Drugs Market

10.1. India Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anticoccidial Drugs Market

11.1. Japan Anticoccidial Drugs Market Overview

11.2. Japan Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anticoccidial Drugs Market

12.1. Australia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anticoccidial Drugs Market

13.1. Indonesia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anticoccidial Drugs Market

14.1. South Korea Anticoccidial Drugs Market Overview

14.2. South Korea Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anticoccidial Drugs Market

15.1. Western Europe Anticoccidial Drugs Market Overview

15.2. Western Europe Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anticoccidial Drugs Market

16.1. UK Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anticoccidial Drugs Market

17.1. Germany Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anticoccidial Drugs Market

18.1. France Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anticoccidial Drugs Market

19.1. Italy Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anticoccidial Drugs Market

20.1. Spain Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anticoccidial Drugs Market

21.1. Eastern Europe Anticoccidial Drugs Market Overview

21.2. Eastern Europe Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anticoccidial Drugs Market

22.1. Russia Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anticoccidial Drugs Market

23.1. North America Anticoccidial Drugs Market Overview

23.2. North America Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anticoccidial Drugs Market

24.1. USA Anticoccidial Drugs Market Overview

24.2. USA Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anticoccidial Drugs Market

25.1. Canada Anticoccidial Drugs Market Overview

25.2. Canada Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anticoccidial Drugs Market

26.1. South America Anticoccidial Drugs Market Overview

26.2. South America Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anticoccidial Drugs Market

27.1. Brazil Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anticoccidial Drugs Market

28.1. Middle East Anticoccidial Drugs Market Overview

28.2. Middle East Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anticoccidial Drugs Market

29.1. Africa Anticoccidial Drugs Market Overview

29.2. Africa Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anticoccidial Drugs Market Competitive Landscape And Company Profiles

30.1. Anticoccidial Drugs Market Competitive Landscape

30.2. Anticoccidial Drugs Market Company Profiles

30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Merck and Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eli Lilly and Company Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Anticoccidial Drugs Market Other Major And Innovative Companies

31.1. Boehringer Ingelheim GmbH

31.2. Zoetis Inc.

31.3. Elanco Animal Health Incorporated

31.4. Intas Pharmaceuticals Ltd.

31.5. Ceva Santé Animale S.A.

31.6. Virbac S.A.

31.7. Phibro Animal Health Corporation

31.8. Vetoquinol SA

31.9. Alpharma BVBA

31.10. Kepro B.V.

31.11. Kemin Industries Inc.

31.12. Tianjin Ringpu Bio-Technology Co. Ltd.

31.13. Hester Biosciences Limited

31.14. Huvepharma AD

31.15. Biovet S.A.

32. Global Anticoccidial Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anticoccidial Drugs Market

34. Recent Developments In The Anticoccidial Drugs Market

35. Anticoccidial Drugs Market High Potential Countries, Segments and Strategies

35.1 Anticoccidial Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Anticoccidial Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Anticoccidial Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Anticoccidial Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Anticoccidial Drugs Market, Sub-Segmentation Of Ionophore, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Anticoccidial Drugs Market, Sub-Segmentation Of Antibiotic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Anticoccidial Drugs Market, Sub-Segmentation Of Sulphonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Anticoccidial Drugs Market, Sub-Segmentation Of Chemical Derivative, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Anticoccidial Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Anticoccidial Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Anticoccidial Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Johnson & Johnson Financial Performance
  • Table 81: Merck and Co. Inc. Financial Performance
  • Table 82: Bayer AG Financial Performance
  • Table 83: Novartis AG Financial Performance
  • Table 84: Eli Lilly and Company Ltd Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Anticoccidial Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Anticoccidial Drugs Market, Sub-Segmentation Of Ionophore, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Anticoccidial Drugs Market, Sub-Segmentation Of Antibiotic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Anticoccidial Drugs Market, Sub-Segmentation Of Sulphonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Anticoccidial Drugs Market, Sub-Segmentation Of Chemical Derivative, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Anticoccidial Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Anticoccidial Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Anticoccidial Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Anticoccidial Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Anticoccidial Drugs Market, Segmentation By Drug Action, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Anticoccidial Drugs Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Johnson & Johnson Financial Performance
  • Figure 81: Merck and Co. Inc. Financial Performance
  • Figure 82: Bayer AG Financial Performance
  • Figure 83: Novartis AG Financial Performance
  • Figure 84: Eli Lilly and Company Ltd Financial Performance

Frequently Asked Questions

Anticoccidial drugs are a class of medications used to prevent and treat coccidiosis, a parasitic disease of the intestinal tract caused by protozoa of the genus Eimeria. These drugs work by inhibiting various stages of the coccidia life cycle, controlling the infection, and preventing the severe intestinal damage and related symptoms associated with the disease. Anticoccidial drugs are commonly used in veterinary medicine, particularly poultry, to enhance health and productivity by managing this widespread and economically significant condition. For further insights on this market, request a sample here

The market major growth driver - Impact Of Growing Demand For Meat Proteins In The Anticoccidial Drug Market. For further insights on this market, request a sample here

The anticoccidial drugs market size has grown strongly in recent years. It will grow from $1.27 billion in 2024 to $1.35 billion in 2025 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increased incidence of coccidiosis globally, increased adoption of pet animals, high prevalence of coccidiosis, economic impact, and increased safety concerns about food and health of animals. The anticoccidial drugs market size is expected to see strong growth in the next few years. It will grow to " $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the growing number of veterinary healthcare, the rising prevalence of coccidiosis in animals, the increasing use of synthetic drugs, the growing demand for feed additives, and increasing livestock production. Major trends in the forecast period include the surge in demand driven by emerging coccidiosis strains, a shift towards natural and alternative treatment methods, increased regulatory scrutiny prompting innovation, rising consumer preferences for antibiotic-free poultry products, advancements in drug delivery technologies, heightened focus on preventive healthcare measures, and expanding applications in aquaculture and companion animal sectors. For further insights on this market, request a sample here

The anticoccidial drugs market covered in this report is segmented –
1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes
2) By Drug Action: Coccidiostatic, Coccidiocidal
3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals
4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels Subsegments:
1) By Ionophore: Monensin, Lasalocid, Salinomycin
2) By Antibiotic: Tylosin, Lincomycin, Bacitracin
3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline
4) By Chemical Derivative: Diclazuril, Clopidol
5) By Other Drug Classes: Amprolium, Robenidine For further insights on this market,
request a sample here

North America was the largest region in the anticoccidial drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd. For further insights on this market, request a sample here.

Major trends in this market include Innovative Synthetic Drugs In Anticoccidial Drug Development. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon